Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+17.95%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$10.2B
AUM Growth
+$1.96B
(+24%)
Cap. Flow
+$684M
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
43.19%
Holding
1,081
New
132
Increased
418
Reduced
456
Closed
74
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$295M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$118M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$97.9M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$55.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$27.6M |
Top Sells
| 1 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$107M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$32.9M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$17.7M |
| 4 |
Lockheed Martin
LMT
|
+$13.5M |
| 5 |
Apple
AAPL
|
+$10.9M |
Sector Composition
| 1 | Technology | 26.66% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 3.24% |
| 4 | Energy | 3.1% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
526
DELISTED
Clovis Oncology, Inc.
CLVS
| $923K | 0.01% |
192,208
-136,295
| -41% | -$655K |
|
527
Rocket Companies
RKT
$43.1B
| $919K | 0.01% |
45,447
+12,527
| +38% | +$253K |
|
|
BHVN
528
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $915K | 0.01% |
10,680
-22,928
| -68% | -$1.96M |
|
|
BPMC
529
DELISTED
Blueprint Medicines
BPMC
| $912K | 0.01% |
8,128
-21,730
| -73% | -$2.44M |
|
530
Karyopharm Therapeutics
KPTI
$54.9M
| $912K | 0.01% |
3,929
-5,386
| -58% | -$1.25M |
|
531
Viatris
VTRS
$12.2B
| $895K | 0.01% |
47,774
+13,735
| +40% | +$257K |
|
532
Matsons
MATX
$3.29B
| $893K | 0.01% |
15,673
+5,584
| +55% | +$318K |
|
533
Ultragenyx Pharmaceutical
RARE
$3.04B
| $891K | 0.01% |
6,433
-20,440
| -76% | -$2.83M |
|
534
United Airlines
UAL
$34.2B
| $890K | 0.01% |
20,570
+5,536
| +37% | +$240K |
|
535
Beam Therapeutics
BEAM
$2.06B
| $884K | 0.01% |
+10,825
| New | +$884K |
|
536
CBRE Group
CBRE
$48.2B
| $883K | 0.01% |
14,072
-235
| -2% | -$14.7K |
|
|
FLIR
537
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $882K | 0.01% |
20,115
-536
| -3% | -$23.5K |
|
|
ALLK
538
DELISTED
Allakos
ALLK
| $881K | 0.01% |
6,291
-14,745
| -70% | -$2.06M |
|
539
PTC Therapeutics
PTCT
$4.64B
| $876K | 0.01% |
14,347
-29,166
| -67% | -$1.78M |
|
540
Tenable Holdings
TENB
$3.73B
| $875K | 0.01% |
+16,749
| New | +$875K |
|
541
Alkermes
ALKS
$4.6B
| $873K | 0.01% |
43,766
-70,266
| -62% | -$1.4M |
|
542
Iovance Biotherapeutics
IOVA
$858M
| $866K | 0.01% |
18,663
-43,929
| -70% | -$2.04M |
|
543
SouthState Bank Corporation
SSB
$10.2B
| $859K | 0.01% |
11,883
-6,187
| -34% | -$447K |
|
|
MRTX
544
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $859K | 0.01% |
3,912
-11,109
| -74% | -$2.44M |
|
545
Texas Capital Bancshares
TCBI
$3.96B
| $858K | 0.01% |
14,427
-10,765
| -43% | -$640K |
|
546
Allogene Therapeutics
ALLO
$253M
| $858K | 0.01% |
33,998
-27,279
| -45% | -$688K |
|
547
Teladoc Health
TDOC
$1.38B
| $857K | 0.01% |
4,287
+901
| +27% | +$180K |
|
548
Caterpillar
CAT
$196B
| $855K | 0.01% |
4,695
+1,304
| +38% | +$237K |
|
549
Veeva Systems
VEEV
$46.3B
| $853K | 0.01% |
3,133
+561
| +22% | +$153K |
|
550
Boston Scientific
BSX
$160B
| $849K | 0.01% |
23,603
-2,217
| -9% | -$79.7K |
|